Proactive Investors - Run By Investors For Investors

Redx Pharma to refocus on key assets

Neil Murray, chief executive at Redx Pharma Plc (LON:REDX), ran through with Proactive the company's full year results to the end of September as well as outlining plans to refocus the business to concentrate on key assets in oncology and immunology - namely Porcupine and BTK.

Meet Sayona Mining Ltd, Lithium Power International Ltd, Elementos, Tyranna Resources and Bryah Resources at our event, Sydney, 26 July 2017. Register here »
View full REDX profile View Profile

Redx Pharma Plc Timeline

CN Research
April 06 2017

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use